Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
IT0005108359
Fri, 25.02.2022       Cassiopea S.p.A.
IT0005108359

Cassiopea S.p.A. / Key word(s): Delisting Cassiopea SpA announces approval of delisting of its shares on SIX Swiss Exchange 25.02.2022 / 07:00 Lainate, Italy - February 25, 2022: Cassiopea S.p.A. (SIX: SKIN), ('Cassiopea'), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel [ … ]
Technical analysis
To the publication
Fri, 04.02.2022       Cassiopea S.p.A.
IT0005108359

Ad hoc announcement pursuant to Art. 53 LR Lainate, Italy, February 4, 2022: Cassiopea S.p.A. (SIX: SKIN) ('Cassiopea') today announced that it has filed for delisting of its registered shares from SIX Swiss Exchange ('SIX'). Cassiopea has applied for a last trading day on March 4, 2022, which is subject to the approval by SIX. About Cassiopea Cas [ … ]
Technical analysis
To the publication
Thu, 20.01.2022       Cassiopea S.p.A.
IT0005108359

Cassiopea S.p.A. / Key word(s): Miscellaneous Cassiopea SpA announces preparing delisting of shares on SIX Swiss Exchange 20.01.2022 / 07:00 Lainate, Italy - January 20, 2022: Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action [ … ]
Technical analysis
To the publication
Fri, 17.12.2021       Cassiopea S.p.A.
IT0005108359

Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland and Lainate, Italy - 17 December 2021 - Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo") and Cassiopea S.p.A. (SIX: SKIN) ("Cassiopea") announce the settlement of the public exchange offer by Cosmo in accordance with articles 125 et seq. of the Federal Act on Financial Markets Infrastructur [ … ]
Technical analysis
To the publication
Tue, 07.12.2021       Cassiopea S.p.A.
IT0005108359

Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland and Lainate, Italy - 7 December 2021 - Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo") and Cassiopea S.p.A. (SIX: SKIN) ("Cassiopea") today announced the definitive final results for the public exchange offer by Cosmo in accordance with articles 125 et seq. of the Federal Act on Financial  [ … ]
Technical analysis
To the publication
Fri, 03.12.2021       Cassiopea S.p.A.
IT0005108359

Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland and Lainate, Italy - 3 December 2021 - Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo") and Cassiopea S.p.A. (SIX: SKIN) ("Cassiopea") today announced the provisional final results for the public exchange offer by Cosmo in accordance with articles 125 et seq. of the Federal Act on Financial [ … ]
Technical analysis
To the publication
Thu, 18.11.2021       Cassiopea S.p.A.
IT0005108359

About Cosmo Pharmaceuticals Cosmo is a specialty pharmaceutical company focused on developing and commercialising products to treat selected gastrointestinal disorders and improve endoscopy quality measures through aiding the detection of colonic lesions. Cosmo has also developed medical devices for endoscopy and has a partnership with Medtronic f [ … ]
Technical analysis
To the publication
Tue, 16.11.2021       Cassiopea S.p.A.
IT0005108359

Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland and Lainate, Italy - 16 November 2021 - Cosmo Pharmaceuticals N.V. (SIX: COPN) ("Cosmo") and Cassiopea S.p.A. (SIX: SKIN) ("Cassiopea") announced today that during the offer period of the public exchange offer in Switzerland for Cosmo to acquire all of the publicly held registered shares of [ … ]
Technical analysis
To the publication
Wed, 03.11.2021       Cassiopea S.p.A.
IT0005108359

EQS Group-News: Cassiopea S.p.A. / Key word(s): Product Launch Cassiopea SpA announces the US launch of Winlevi(R) (clascoterone cream 1%) 03.11.2021 / 07:00 Lainate, Italy, November 3, 2021: Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mech [ … ]
Technical analysis
To the publication
Mon, 04.10.2021       Cassiopea S.p.A.
IT0005108359

Ad hoc announcement pursuant to Art. 53 LR Dublin, Ireland and Lainate, Italy - 4 October 2021 - Today, Cosmo Pharmaceuticals N.V. launches a public exchange offer under Swiss takeover rules to fully acquire and delist Cassiopea S.p.A. The exchange ratio follows current market prices. Further information is available on https://www.cosmopharma.co [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 22.09.2024, Calendar Week 38, 266th day of the year, 100 days remaining until EoY.